Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PIOGLITAZONE HYDROCHLORIDE USP (NON STERILE DRUG SUBSTANCE), with a corresponding US DMF Number 22865.
Remarkably, this DMF maintains an Active status since its submission on June 12, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 27, 2014, and payment made on January 16, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II